Abstract
Purpose
Arterial feeders supplying a hepatocellular carcinoma are known to be interconnected through the sinusoid-like tumor vasculature. It was observed angiographically that when one of the feeders is selectively catheterized for drug delivery in transarterial chemoembolization (TACE), the whole tumor vasculature will be filled up, if the arterial inflow from all the other feeders is temporarily arrested with selective occlusion of feeding arteries (SOFA) using an additional catheter (balloon catheter). The feasibility of using the SOFA technique in TACE (SOFA-TACE) is discussed.
Materials and Methods
In this prospective, monocentric feasibility study, with informed consent obtained, 8 consecutive patients of median age 64.5 years (60–68.8) and tumor dimension 4.7 cm (3.2–6.1), having specific tumor features (solitary, hypervascularity, well-defined, ≤ 7 cm, multiple tumor feeders), received SOFA-TACE using ethiodized oil–cisplatin suspension. Tumor response was assessed with 3-monthly CT using modified RECIST.
Results
A single tumor feeder was catheterized for drug delivery (8 cases). All other tumor feeders were successfully occluded with a balloon at one site (8 cases). Complete filling of the vasculature of the whole tumor was achieved in 7 of 8 cases with the SOFA technique as shown on arteriogram and CT, except in a case with an intratumoral septum. There was no complication. Surveillance CT (median 25 months, range 22–28) showed complete response in all cases.
Conclusion
SOFA-TACE is feasible with reasonable safety and favorable treatment outcome; it may be a valuable technical option that may facilitate the procedures of selective TACE in technically challenging cases.
References
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. https://doi.org/10.1016/j.jhep.2018.03.019
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, et al. Diagnosis staging, and management of hepatocellular carcinoma, practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;2018(68):723–50. https://doi.org/10.1002/hep.29913.
Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317–70. https://doi.org/10.1007/s12072-017-9799-9.
Vitale A, Trevisani F, Farinati F, et al. Treatment of hepatocellular carcinoma in the precision medicine era: from treatment stage migration to therapeutic hierarchy. Hepatology. 2020. https://doi.org/10.1002/hep.31187.
Yamakado K, Miyayama S, Hirota S, Mizunuma K, Nakamura K, Inaba Y, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012;30:560–6. https://doi.org/10.1007/s11604-012-0088-1.
Golfieri R, Renzulli M, Mosconi C, Forlani L, Giampalma E, Piscaglia F, et al. Hepatocellular carcinoma responding to superselective transarterial chemoembolization : an issue of nodule dimension? J Vasc Interv Radiol. 2013;24:509–17.
Miyayama S, Matsui O. Superselective conventional transarterial chemoembolization for hepatocellular carcinoma: rationale, technique, and outcome. J Vasc Interv Radiol. 2016;27:1269–78.
Miyayama S. Ultraselective conventional transarterial chemoembolization: when and how? Clin Mol Hepatol. 2019;25(4):344–53. https://doi.org/10.3350/cmh.2019.0016.
Hiraoka A, Kumada T, Kudo M, et al. Hepatic function during repeated TACE procedures and prognosis after introducing sorafenib in patients with unresectable hepatocellular carcinoma: multicenter analysis. Dig Dis. 2017;35:602–10. https://doi.org/10.1159/000480256.
Cui Z, Shukla PA, Habibollahi P, Park HS, Fischman A, Kolber MK. A systematic review of automated feeder detection software for locoregional treatment of hepatic tumors. Diagn Interv Imaging. 2020;101:439–49.
Ueda K, Matsui O, Kawamori Y, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology. 1998. https://doi.org/10.1148/radiology.206.1.9423667.
Fournier L, Ammari S, Thiam R, Cuénod CA. Imaging criteria for assessing tumour response: RECIST, mRECIST. Cheson, Diagn Interv Imaging. 2014;95:689–703. https://doi.org/10.1016/j.diii.2014.05.002.
Irie T, Kuramochi M, Takahashi N. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol. 2013;36:706–13. https://doi.org/10.1007/s00270-012-0476-z.
Irie T, Kuramochi M, Kamoshida T, et al. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatol Res. 2016;46:209–14. https://doi.org/10.1111/hepr.12564.
Lucatelli P, Corradini LG, De Rubeis G, Rocco B, Basilico F, Cannavale A, et al. Balloon-occluded transcatheter arterial chemoembolization (b-TACE) for hepatocellular carcinoma performed with polyethylene-glycol epirubicin-loaded drug-eluting embolics: safety and preliminary results. Cardiovasc Intervent Radiol. 2019;42:853–62. https://doi.org/10.1007/s00270-019-02192-y.
Lucatelli P, De Rubeis G, Rocco B, Basilico F, Cannavale A, Abbatecola A, et al. Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study. BMC Gastroenterol. 2021;21:51. https://doi.org/10.1186/s12876-021-01631-w.
Golfieri R, Bezzi M, Verset G, Fucilli F, Cappelli A, Mosconi C, et al. Retrospective European multicentric evaluation of selective transarterial chemoembolisation with and without balloon-occlusion in patients with hepatocellular carcinoma: a propensity score matched analysis. Cardiovasc Intervent Radiol. 2021. https://doi.org/10.1007/s00270-021-02805-5.
Funding
Vascular and Interventional Radiology Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This paper has not been presented at an Annual Scientific Meeting of the Cardiovascular and Interventional Radiology Society of Europe.
Rights and permissions
About this article
Cite this article
Yu, S.C.H. Blood Flow Diversion Within Hepatocellular Carcinoma (HCC) after Selective Occlusion of Feeding Arteries (SOFA) and Feasibility of Utilizing the SOFA Technique in Transarterial Chemoembolization (SOFA-TACE). Cardiovasc Intervent Radiol 45, 121–126 (2022). https://doi.org/10.1007/s00270-021-02973-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-021-02973-4